BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31593523)

  • 41. Study protocol: assessing the association between corporate financial influence and implementation of policies to tackle commercial determinants of non-communicable diseases: a cross-sectional analysis of 172 countries.
    Allen LN; Wigley S; Holmer H
    BMJ Open; 2022 Aug; 12(8):e055656. PubMed ID: 36041766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Industry funding of patient and health consumer organisations: systematic review with meta-analysis.
    Fabbri A; Parker L; Colombo C; Mosconi P; Barbara G; Frattaruolo MP; Lau E; Kroeger CM; Lunny C; Salzwedel DM; Mintzes B
    BMJ; 2020 Jan; 368():l6925. PubMed ID: 31969320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. U.S. research universities' institutional conflict of interest policies.
    Slaughter S; Feldman MP; Thomas SL
    J Empir Res Hum Res Ethics; 2009 Sep; 4(3):3-20. PubMed ID: 19754230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strengthening conflict-of-interest policies in medicine.
    Cosgrove L; Bursztajn HJ
    J Eval Clin Pract; 2010 Feb; 16(1):21-4. PubMed ID: 19874437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What do we really know about conflicts of interest in biomedical research?
    Warner TD; Gluck JP
    Psychopharmacology (Berl); 2003 Dec; 171(1):36-46. PubMed ID: 14624332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
    Newcombe JP; Kerridge IH
    Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disclosing conflicts of interest to research subjects: an ethical and legal analysis.
    Resnik DB
    Account Res; 2004; 11(2):141-59. PubMed ID: 15675055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Institutional Conflict of Interest Policies at U.S. Academic Research Institutions.
    Resnik DB; Ariansen JL; Jamal J; Kissling GE
    Acad Med; 2016 Feb; 91(2):242-6. PubMed ID: 26535868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Eur Heart J; 2012 Mar; 33(5):587-94. PubMed ID: 22383145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conflicts of interest: conceptual and normative issues.
    Pritchard MS
    Acad Med; 1996 Dec; 71(12):1305-13. PubMed ID: 9114888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Society for Maternal-Fetal Medicine Special Statement: Society for Maternal-Fetal Medicine's conflict of interest policy.
    ; Waters T; McNulty J; Wylie B; Sciscione A; Iriye B
    Am J Obstet Gynecol; 2020 Dec; 223(6):B47-B57.e3. PubMed ID: 32971012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conflict of interest policies for organizations producing a large number of clinical practice guidelines.
    Norris SL; Holmer HK; Burda BU; Ogden LA; Fu R
    PLoS One; 2012; 7(5):e37413. PubMed ID: 22629391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Innovation incentives or corrupt conflicts of interest? Moving beyond Jekyll and Hyde in regulating biomedical academic-industry relationships.
    Taylor PL
    Yale J Health Policy Law Ethics; 2013; 13(1):135-97. PubMed ID: 23815042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 'Public enemy no. 1': Tobacco industry funding for the AIDS response.
    Smith J; Thompson S; Lee K
    SAHARA J; 2016; 13(1):41-52. PubMed ID: 27023371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Rev Port Cardiol; 2012 Apr; 31(4):329-36. PubMed ID: 22863109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Food industry donations to patient advocacy organisations focussed on non-communicable diseases.
    Del Giudice IM; Tsai KA; Arshonsky J; Bond S; Bragg MA
    Public Health Nutr; 2022 Oct; 26(3):1-9. PubMed ID: 36305342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Financial conflict-of-interest policies in clinical research: issues for clinical investigators.
    Boyd EA; Cho MK; Bero LA
    Acad Med; 2003 Aug; 78(8):769-74. PubMed ID: 12915362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Confronting conflict: addressing institutional conflicts of interest in academic medical centers.
    Liang BA; Mackey T
    Am J Law Med; 2010; 36(1):136-87. PubMed ID: 20481404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conflict of interest in public health: should there be a law to prevent it?
    Gupta A; Holla R; Suri S
    Indian J Med Ethics; 2015; 12(3):172-7. PubMed ID: 26060144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrinsic conflicts of interest in clinical research: a need for disclosure.
    Sollitto S; Hoffman S; Mehlman M; Lederman RJ; Youngner SJ; Lederman MM
    Kennedy Inst Ethics J; 2003 Jun; 13(2):83-91. PubMed ID: 14569995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.